Micro-cost Analysis of ALK Rearrangement Testing by FISH to Determine Eligibility for Crizotinib Therapy in NSCLC: Implications for Cost Effectiveness of Testing and Treatment
about
Micro-cost Analysis of ALK Rearrangement Testing by FISH to Determine Eligibility for Crizotinib Therapy in NSCLC: Implications for Cost Effectiveness of Testing and Treatment
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Micro-cost Analysis of ALK Rea ...... eness of Testing and Treatment
@ast
Micro-cost Analysis of ALK Rea ...... eness of Testing and Treatment
@en
Micro-cost Analysis of ALK Rea ...... eness of Testing and Treatment
@nl
type
label
Micro-cost Analysis of ALK Rea ...... eness of Testing and Treatment
@ast
Micro-cost Analysis of ALK Rea ...... eness of Testing and Treatment
@en
Micro-cost Analysis of ALK Rea ...... eness of Testing and Treatment
@nl
prefLabel
Micro-cost Analysis of ALK Rea ...... eness of Testing and Treatment
@ast
Micro-cost Analysis of ALK Rea ...... eness of Testing and Treatment
@en
Micro-cost Analysis of ALK Rea ...... eness of Testing and Treatment
@nl
P2860
P356
P1476
Micro-cost Analysis of ALK Rea ...... eness of Testing and Treatment
@en
P2093
David Parker
P2860
P304
P356
10.4137/CMO.S19236
P407
P577
2014-12-08T00:00:00Z